Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Debiopharm International SA
Nuvation Bio Inc.
Alliance for Clinical Trials in Oncology
Virginia Commonwealth University
City of Hope Medical Center
Children's Oncology Group
Taproot Health
University of California, San Francisco
University of California, San Francisco
St. Jude Children's Research Hospital
City of Hope Medical Center
Northwell Health
Northwestern University
Tocagen Inc.
OHSU Knight Cancer Institute
Jonsson Comprehensive Cancer Center
Children's Oncology Group
Duke University
University of South Florida
National Cancer Institute (NCI)
University of Minnesota
Children's Oncology Group
INSYS Therapeutics Inc
Children's Oncology Group
University of South Florida
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Hospital Medical Center, Cincinnati
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center